Financials ResMed, Inc.

Equities

RMD

US7611521078

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 01:30:01 12/09/2024 am IST			5-day change	1st Jan Change
252.92 ^USD	+0.02%		+3.34%	+47.03%

11/09	ResMed Insider Sold Shares Worth $3,646,950, According to a Recent SEC Filing	MT
06/09	Resmed Insider Sold Shares Worth $479,800, According to a Recent SEC Filing	MT

Projected Income Statement: ResMed, Inc.

Fiscal Period: June	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	2,957	3,197	3,578	4,223	4,685	5,046	5,397	5,737
Change	-	8.11%	11.93%	18.02%	10.95%	7.69%	6.97%	6.3%
EBITDA ¹	966	1,074	1,162	1,317	1,576	1,786	1,937	2,070
Change	-	11.21%	8.14%	13.38%	19.63%	13.31%	8.47%	6.9%
EBIT ¹	811.2	903.7	1,000	1,224	1,478	1,685	1,836	1,961
Change	-	11.41%	10.69%	22.41%	20.74%	14%	8.97%	6.76%
Interest Paid ¹	-39.36	-23.63	-22.31	-47.38	-45.71	-5.85	-10.2	-2
Earnings before Tax (EBT) ¹	733.1	883.7	960.5	1,102	1,265	1,614	1,773	1,916
Change	-	20.54%	8.69%	14.7%	14.81%	27.65%	9.83%	8.05%
Net income ¹	621.7	474.5	779.4	897.6	1,021	1,297	1,433	1,562
Change	-	-23.67%	64.26%	15.15%	13.75%	27.05%	10.51%	8.96%
Announcement Date	05/08/20	05/08/21	11/08/22	03/08/23	01/08/24	-	-	-

¹USD in Million

Estimates

Fiscal Period: June	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	681.1	736.2	769.5	770.3	751.9	800	768.8	876.1	904	894.9	864.5	914.7	950.3	1,034	1,117	1,122	1,102	1,163	1,197	1,223	1,187	1,255	1,284	1,315	1,258	1,326	1,361	1,397
Change	-	8.09%	4.52%	0.12%	-2.39%	6.39%	-3.91%	13.96%	3.19%	-1.01%	-3.39%	5.81%	3.89%	8.78%	8.04%	0.46%	-1.76%	5.49%	2.94%	2.19%	-2.94%	5.67%	2.37%	2.4%	-4.33%	5.42%	2.58%	2.69%
EBITDA ¹	209.1	237	256.8	261.8	256.4	276.2	263.4	278.4	301	289.5	276.6	294.7	312.8	326.4	345	333	363.7	390.5	418.1	424.9	414.6	450.7	463.9	473.1	456.8	488	504.3	504.2
Change	-	13.36%	8.34%	1.94%	-2.06%	7.74%	-4.63%	5.67%	8.14%	-3.83%	-4.47%	6.54%	6.14%	4.35%	5.72%	-3.49%	9.22%	7.35%	7.07%	1.64%	-2.42%	8.71%	2.92%	2%	-3.46%	6.83%	3.35%	-0.02%
EBIT ¹	171.1	197.8	217.5	223.2	216.9	221.7	223.4	241.6	261.9	248.7	234.3	255.4	290.8	305.5	321.2	307	318.8	365.5	393.6	400.5	384.9	421.9	433.3	442.7	424	460	470	476
Change	-	15.61%	9.95%	2.64%	-2.84%	2.22%	0.77%	8.15%	8.39%	-5.04%	-5.81%	9.02%	13.87%	5.04%	5.14%	-4.43%	3.85%	14.66%	7.69%	1.74%	-3.87%	9.61%	2.69%	2.16%	-4.21%	8.49%	2.17%	1.28%
Charge d'intérêts ¹	-10.54	-10.02	-9.852	-8.942	-6.725	-5.792	-5.823	-5.286	-5.36	-5.792	-5.462	-5.542	-7.134	-10.34	-14.96	-14.94	-14.96	-13.8	-11.03	-5.92	-2.5	-1.25	-5.667	-8	-1	-1	-1	-1
Earnings before Tax (EBT) ¹	150.6	178.8	191.7	212.1	215.9	210.6	218	239.2	258.8	237.3	226.3	238.1	261.8	273.7	289.4	276.8	272.2	259.5	375.4	357.7	364.1	402.2	417.9	433.1	420	445	459	478
Change	-	18.7%	7.22%	10.66%	1.77%	-2.44%	3.52%	9.73%	8.18%	-8.31%	-4.62%	5.2%	9.96%	4.54%	5.73%	-4.35%	-1.67%	-4.68%	44.7%	-4.71%	1.78%	10.48%	3.9%	3.62%	-3.01%	5.95%	3.15%	4.14%
Net income ¹	120.1	160.6	163.1	177.8	178.4	179.5	-78.48	195.1	203.6	201.8	179	195.1	210.5	224.9	232.5	229.7	219.4	208.8	300.5	292.2	293.4	324.1	336.3	347	329.5	354	363.5	374
Change	-	33.63%	1.61%	9.01%	0.3%	0.64%	-	-	4.36%	-0.91%	-11.27%	8.97%	7.9%	6.86%	3.37%	-1.22%	-4.46%	-4.84%	43.91%	-2.75%	0.41%	10.45%	3.77%	3.18%	-5.04%	7.44%	2.68%	2.89%
Announcement Date	24/10/19	30/01/20	30/04/20	05/08/20	29/10/20	28/01/21	29/04/21	05/08/21	28/10/21	27/01/22	28/04/22	11/08/22	27/10/22	26/01/23	27/04/23	03/08/23	26/10/23	24/01/24	25/04/24	01/08/24	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: ResMed, Inc.

Fiscal Period: June	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	713	360	502	1,213	469	-289	-1,261	-2,277
Change	-	-49.51%	39.44%	141.63%	-61.34%	-161.64%	-536.33%	-280.57%
Announcement Date	05/08/20	05/08/21	11/08/22	03/08/23	01/08/24	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: ResMed, Inc.

Fiscal Period: June	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	95.33	102.7	134.8	119.7	99.46	127.5	140.5	158.3
Change	-	7.74%	31.27%	-11.25%	-16.89%	28.24%	10.19%	12.62%
Free Cash Flow (FCF) ¹	706.9	634	216.3	573.6	1,302	1,206	1,464	1,547
Change	-	-10.31%	-65.88%	165.19%	126.94%	-7.33%	21.32%	5.7%
Announcement Date	05/08/20	05/08/21	11/08/22	03/08/23	01/08/24	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: ResMed, Inc.

Fiscal Period: June	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	32.67%	33.61%	32.47%	31.19%	33.63%	35.39%	35.89%	36.09%
EBIT Margin (%)	27.43%	28.27%	27.96%	28.99%	31.55%	33.4%	34.02%	34.17%
EBT Margin (%)	24.79%	27.64%	26.84%	26.09%	27%	32%	32.85%	33.39%
Net margin (%)	21.02%	14.84%	21.78%	21.25%	21.79%	25.71%	26.56%	27.22%
FCF margin (%)	23.91%	19.83%	6.05%	13.58%	27.78%	23.91%	27.12%	26.96%
FCF / Net Income (%)	113.71%	133.61%	27.75%	63.91%	127.51%	93.01%	102.1%	99.06%
Profitability
ROA	14.3%	16.76%	17.32%	16.03%	16.72%	18.67%	18.51%	17.33%
ROE	27.21%	29%	27.24%	25.36%	25.33%	24.68%	23.53%	22.06%
Financial Health
Leverage (Debt/EBITDA)	0.74x	0.34x	0.43x	0.92x	0.3x	-	-	-
Debt / Free cash flow	1.01x	0.57x	2.32x	2.12x	0.36x	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	3.22%	3.21%	3.77%	2.83%	2.12%	2.53%	2.6%	2.76%
CAPEX / EBITDA (%)	9.87%	9.56%	11.61%	9.09%	6.31%	7.14%	7.26%	7.64%
CAPEX / FCF (%)	13.49%	16.2%	62.33%	20.86%	7.64%	10.57%	9.6%	10.23%
Items per share
Cash flow per share ¹	5.508	5.03	2.388	4.702	9.497	9.092	10.64	-
Change	-	-8.68%	-52.52%	96.88%	101.98%	-4.26%	17.03%	-
Dividend per Share ¹	1.56	1.56	1.68	1.8	-	2.243	2.404	2.615
Change	-	0%	7.69%	7.14%	-	-	7.2%	8.76%
Book Value Per Share ¹	17.3	19.86	22.42	28.14	-	39.86	47.34	57.23
Change	-	14.79%	12.91%	25.51%	-	-	18.78%	20.88%
EPS ¹	4.27	3.24	5.3	6.09	6.92	8.76	9.66	10.43
Change	-	-24.12%	63.58%	14.91%	13.63%	26.59%	10.27%	7.94%
Nbr of stocks (in thousands)	1,44,668	1,45,640	1,46,405	1,47,062	1,46,884	1,46,932	1,46,932	1,46,932
Announcement Date	05/08/20	05/08/21	11/08/22	03/08/23	01/08/24	-	-	-